cml {currentSurvival}

Data of Patients With Chronic Myeloid Leukaemia

Description

data of patients with chronic myeloid leukaemia

Usage

data(cml)

Format

A data frame with 104 observations on the following 10 variables.

CCgR01

time from therapy initiation to achievement of the first disease remission

loss_CCgR01

time from therapy initiation to loss of the first disease remission

CCgR02

time from therapy initiation to achievement of the second disease remission

loss_CCgR02

time from therapy initiation to loss of the second disease remission

CCgR03

time from therapy initiation to achievement of the third disease remission

follow.up

follow-up time (time from therapy initiation to death or to the date of last contact with a patient)

death

censoring indicator (1..patient died, 0..patient is censored)

sokal

Sokal score (1..low-risk, 2..intermediate-risk, 3..high-risk)

euro

Euro score (1..low-risk, 2..intermediate-risk, 3..high-risk)

eutos

EUTOS score (0..low-risk, 1..high-risk)

Source

population-based, observational study, INFINITY (https://www.leukemia-cell.org/index-en.php?pg=infinity–project-information)

References

Pavlik T., Janousova E., Pospisil Z., et al. (2011). Estimation of current cumulative incidence of leukaemia-free patients and current leukaemia-free survival in chronic myeloid leukaemia in the era of modern pharmacotherapy. BMC Med Res Methodol 11:140.

Examples

data(cml)
str(cml)